Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers
Open Access
- 5 August 2024
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 23 (9) , 100826
Abstract
No abstract availableKeywords
Funding Information
- Kyung Hee University
- Korea Health Industry Development Institute
- Ministry of Health and Welfare (HI17C0778, HR22C1605)
This publication has 32 references indexed in Scilit:
- Placenta morphology and biomarkers in pregnancies with congenital heart disease – A systematic reviewPlacenta, 2021
- A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsiaInternational Journal of Gynecology & Obstetrics, 2021
- Stratification of pregnancy care based on risk of pre‐eclampsia derived from biophysical and biochemical markers at 19–24 weeks' gestationUltrasound in Obstetrics & Gynecology, 2021
- Adenosine and preeclampsiaMolecular Aspects of Medicine, 2017
- Relationship between hypoxia and downstream pathogenic pathways in preeclampsiaHypertension in Pregnancy, 2017
- Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21The Journal of Molecular Diagnostics, 2016
- Expression changes of proteins associated with the development of preeclampsia in maternal plasma: A case‐control studyProteomics, 2016
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular EventsNew England Journal of Medicine, 2014
- Early Disturbed Placental Ischemia and Hypoxia Creates Immune Alteration and Vascular Disorder Causing PreeclampsiaArchives of Medical Research, 2014